Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8417148rdf:typepubmed:Citationlld:pubmed
pubmed-article:8417148lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0815000lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0256371lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C1823153lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0475264lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0439097lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C2349976lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C1552644lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C1547348lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:8417148lifeskim:mentionsumls-concept:C0439098lld:lifeskim
pubmed-article:8417148pubmed:issue1lld:pubmed
pubmed-article:8417148pubmed:dateCreated1993-1-25lld:pubmed
pubmed-article:8417148pubmed:abstractTextA decrease in protein kinase C activity caused either by treatment with inhibitors, such as staurosporine or H-7, or by prolonged exposure to phorbol diesters has been proposed to be involved in the early events of SH-SY5Y neuroblastoma cell differentiation. Because eight distinct isoforms of protein kinase C with discrete subcellular and tissue distributions have been described, we determined which isoforms are present in SH-SY5Y cells and studied their modifications during differentiation. The alpha, beta 1, delta, and epsilon isoforms were present in SH-SY5Y cells, as well as in rat brain. Protein kinase C-alpha and -beta 1 were the most abundant isoforms in SH-SY5Y cells, and immunoreactive protein kinase C-delta and -epsilon were present in much smaller amounts than in rat brain. Subcellular fractionation and immunocytochemistry demonstrated that all four isoforms are distributed bimodally in the cytoplasm and the membranes. Immunocytochemical analysis showed that the alpha isoform is associated predominantly with the plasma membrane and the processes extended during treatment with 12-tetradecanoyl-13-acetyl-beta-phorbol or staurosporine, and that protein kinase C-epsilon is predominantly membrane-bound. Its localization did not change during differentiation. Western blots of total SH-SY5Y cell extracts and of subcellular fractions probed with isoform-specific polyclonal antibodies showed that when SH-SY5Y cells acquired a morphologically differentiated phenotype, protein kinase C-alpha and -epsilon decreased, and protein kinase C-beta 1 did not change. These data suggest distinct roles for the different protein kinase C isoforms during neuronal differentiation, as well as possible involvement of protein kinase alpha and epsilon in neuritogenesis.lld:pubmed
pubmed-article:8417148pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8417148pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8417148pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8417148pubmed:languageenglld:pubmed
pubmed-article:8417148pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8417148pubmed:citationSubsetIMlld:pubmed
pubmed-article:8417148pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8417148pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8417148pubmed:statusMEDLINElld:pubmed
pubmed-article:8417148pubmed:monthJanlld:pubmed
pubmed-article:8417148pubmed:issn0022-3042lld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:HauserGGlld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:NixonR ARAlld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:SheaT BTBlld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:LiepkalnsV...lld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:ParkerP JPJlld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:LeliUUlld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:BeermannM LMLlld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:CataldoAAlld:pubmed
pubmed-article:8417148pubmed:authorpubmed-author:GrynspanFFlld:pubmed
pubmed-article:8417148pubmed:issnTypePrintlld:pubmed
pubmed-article:8417148pubmed:volume60lld:pubmed
pubmed-article:8417148pubmed:ownerNLMlld:pubmed
pubmed-article:8417148pubmed:authorsCompleteYlld:pubmed
pubmed-article:8417148pubmed:pagination289-98lld:pubmed
pubmed-article:8417148pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:meshHeadingpubmed-meshheading:8417148-...lld:pubmed
pubmed-article:8417148pubmed:year1993lld:pubmed
pubmed-article:8417148pubmed:articleTitleDifferential expression and subcellular localization of protein kinase C alpha, beta, gamma, delta, and epsilon isoforms in SH-SY5Y neuroblastoma cells: modifications during differentiation.lld:pubmed
pubmed-article:8417148pubmed:affiliationRalph Lowell Laboratories, McLean Hospital, Belmont, Massachusetts 02178.lld:pubmed
pubmed-article:8417148pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8417148pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8417148pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:8417148pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8417148lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8417148lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8417148lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8417148lld:pubmed